By Rafi Mahandaru  212
CHARCOT FOOT
By Rafi Mahandaru  212
CHARCOT FOOT
Jean-Marie Charcot
• 29 November 1825 – 16
August 1893
• The father of neurology
• Charcot triad-1  MS
• Charcot triad-2  AC
• Charcot joint, known as
Charcot neuroarthropathy
(CNA)/charcot
osteoarthropathy (COA) /
charcot foot/ neuropathic
joint
DEFINITION
Charcot foot
Charcot foot can be defined as
a relatively painless, progressive and degenerative
arthropathy of single or multiple joints caused by an
underlying neurological deficit.
It was a limbthreatening condition, wich can lead to amputation
ETIOLOGY
Firstly describes 1868
Tabes Dorsalis  late manifestation of shypilis
Bilateral degeneration of axons in BOTH
dorsal columns
• Pain, parestethic, sensory loss
• Muscle stretch reflex also messed up
because the sensory input to those
reflexes have been lesioned
• usually occurs at lumbar levels
Recent common cause
• Complication of diabetes melitus
• is estimated to affect
between 1-2.5% of people with
diabetes (2003)
• It is estimated to affect 0.8%-8% of
diabetic populations (2011)
•At least 10 years suffer
Another rare cause
PATHOPHYSIOLOGY
French Theory
• Charcot 1868  neurovascular theory
• “…the arthropathy of ataxic patients seems to
always start after the sclerotic changes have
taken place in the spinal cord.”
• Spinal cord lesion  autonomic neuropathy 
arterious venous shunting  increase blood flow
 increase osteoclast activity  bone resorption
and mechanical weakening  fractures and
deformity
• Increase blood flow  warmth foot and dilated
veins
German theory (1946)
• Volkman and Virchow  neurotraumatic theory
• “ peripheral neuropathy leading to loss of
protective sensation may render the foot
susceptible to injury from either repeated or
acute trauma “
• Insensitive joint
• Allow mechanical trauma  normaly prevented
by pain
• Spontaneous fracture, subluxation and
dislocation
Other Contributed Factor
• Bone pathology
• Atypical neuropathy
• Non-enzymatic collagen glycation
• Increased plantar pressures
• Excessive local inflammation
Acute Charcot Foot
Acute Charcot Foot
• H : Hminor trauma
• L : Swollen, erythem,
deform
• F : Warmth – hot
• M : Crepitation
• Discomfort 
considerably less than
might be expected
from the pathology
seen
Chronic Charcot foot
Chronic Charcot foot
• L : pemanent deform,
no erythem, reducing
swollen
• F : warmth or hot
temp., subside
• M : no crepitation, gait
tabes dorsalis,
• Sometimes with
unoticed ulcer
Clinical Course
• People risk for Charcot foot  stage 0
• Acute Charcot foot  stage I  Dev-fragmentation
– Swollen, hyperemia, bone fragmentation, join dislocation
and destruction
– Radiological still looks normal, bone debris, joint
subluxation and dislocation subsequently develop
• Chronic Charcot foot  stage II  coalescence
– Decreasing erythem, hot, swelling
– X-Ray :absorption of fine debris,formation of new bone,
coalescence of larger fragments and sclerosis of bone
ends
– Decrease joint mobility
Clinical Course
• Stage III  reconstruction - consolidation
– edema, erythema and warmth are not present,
– unless fractures have not healed
– Ulcers may develop at
– sites of residual deformity, while X-rays reveal
bony remodeling,
– rounding of bone ends and decreased sclerosis
Diagnose
Clinically
• Have been describe above
• Investigation should be make on early stage
and to differentiate between another disease
like Osteomyelitis, Gout, Arthritis
– History
– Predisposising factor
– Physical Examination
– Complication
X - Ray
• Atrophic changes :
“pencil pointing or
sucked candy “
X-Ray
• Hypertropic
changes :
– Bone proliferation
– Bone destruction
– Subcondral sclerosis
and
– Osteophtes may be
seen
Treatment
Conservative
 Immobilization and off loading
• Reducing swelling and mechanical stress 
elevation, bed rest, whell chair
• TCC  Total Contact Cast
Conservative
• Biphosphonat  inhibit Osteoclastic activity
– N-Containing
• Sodium alendronat (fosamax)
• Riserdonat (actonel)
– Non N-Containing
• Etidronat (didronel)
• Tiludronic (skelid)
INTRANASAL
CALCITONIN
Surgery
• Acute Charcot Foot  Contraindicated
• Chronic Ulcerated and fixed deformity 
indication of surgery  remove bony
prominent and correct the deformity
– Exostectomy
– Arthrodesis
– Tendon Lengthening
THANX … !

Charcot foot

  • 1.
    By Rafi Mahandaru 212 CHARCOT FOOT
  • 2.
    By Rafi Mahandaru 212 CHARCOT FOOT
  • 3.
    Jean-Marie Charcot • 29November 1825 – 16 August 1893 • The father of neurology • Charcot triad-1  MS • Charcot triad-2  AC • Charcot joint, known as Charcot neuroarthropathy (CNA)/charcot osteoarthropathy (COA) / charcot foot/ neuropathic joint
  • 4.
  • 5.
    Charcot foot Charcot footcan be defined as a relatively painless, progressive and degenerative arthropathy of single or multiple joints caused by an underlying neurological deficit. It was a limbthreatening condition, wich can lead to amputation
  • 6.
  • 7.
    Firstly describes 1868 TabesDorsalis  late manifestation of shypilis Bilateral degeneration of axons in BOTH dorsal columns • Pain, parestethic, sensory loss • Muscle stretch reflex also messed up because the sensory input to those reflexes have been lesioned • usually occurs at lumbar levels
  • 8.
    Recent common cause •Complication of diabetes melitus • is estimated to affect between 1-2.5% of people with diabetes (2003) • It is estimated to affect 0.8%-8% of diabetic populations (2011) •At least 10 years suffer
  • 9.
  • 10.
  • 11.
    French Theory • Charcot1868  neurovascular theory • “…the arthropathy of ataxic patients seems to always start after the sclerotic changes have taken place in the spinal cord.” • Spinal cord lesion  autonomic neuropathy  arterious venous shunting  increase blood flow  increase osteoclast activity  bone resorption and mechanical weakening  fractures and deformity • Increase blood flow  warmth foot and dilated veins
  • 12.
    German theory (1946) •Volkman and Virchow  neurotraumatic theory • “ peripheral neuropathy leading to loss of protective sensation may render the foot susceptible to injury from either repeated or acute trauma “ • Insensitive joint • Allow mechanical trauma  normaly prevented by pain • Spontaneous fracture, subluxation and dislocation
  • 13.
    Other Contributed Factor •Bone pathology • Atypical neuropathy • Non-enzymatic collagen glycation • Increased plantar pressures • Excessive local inflammation
  • 14.
  • 15.
    Acute Charcot Foot •H : Hminor trauma • L : Swollen, erythem, deform • F : Warmth – hot • M : Crepitation • Discomfort  considerably less than might be expected from the pathology seen
  • 16.
  • 17.
    Chronic Charcot foot •L : pemanent deform, no erythem, reducing swollen • F : warmth or hot temp., subside • M : no crepitation, gait tabes dorsalis, • Sometimes with unoticed ulcer
  • 18.
    Clinical Course • Peoplerisk for Charcot foot  stage 0 • Acute Charcot foot  stage I  Dev-fragmentation – Swollen, hyperemia, bone fragmentation, join dislocation and destruction – Radiological still looks normal, bone debris, joint subluxation and dislocation subsequently develop • Chronic Charcot foot  stage II  coalescence – Decreasing erythem, hot, swelling – X-Ray :absorption of fine debris,formation of new bone, coalescence of larger fragments and sclerosis of bone ends – Decrease joint mobility
  • 19.
    Clinical Course • StageIII  reconstruction - consolidation – edema, erythema and warmth are not present, – unless fractures have not healed – Ulcers may develop at – sites of residual deformity, while X-rays reveal bony remodeling, – rounding of bone ends and decreased sclerosis
  • 20.
  • 21.
    Clinically • Have beendescribe above • Investigation should be make on early stage and to differentiate between another disease like Osteomyelitis, Gout, Arthritis – History – Predisposising factor – Physical Examination – Complication
  • 22.
    X - Ray •Atrophic changes : “pencil pointing or sucked candy “
  • 23.
    X-Ray • Hypertropic changes : –Bone proliferation – Bone destruction – Subcondral sclerosis and – Osteophtes may be seen
  • 25.
  • 26.
    Conservative  Immobilization andoff loading • Reducing swelling and mechanical stress  elevation, bed rest, whell chair • TCC  Total Contact Cast
  • 27.
    Conservative • Biphosphonat inhibit Osteoclastic activity – N-Containing • Sodium alendronat (fosamax) • Riserdonat (actonel) – Non N-Containing • Etidronat (didronel) • Tiludronic (skelid) INTRANASAL CALCITONIN
  • 28.
    Surgery • Acute CharcotFoot  Contraindicated • Chronic Ulcerated and fixed deformity  indication of surgery  remove bony prominent and correct the deformity – Exostectomy – Arthrodesis – Tendon Lengthening
  • 29.